AM
Posted:
June 04, 2026
Location:
toronto, on, Canada
Job Description
Drive MES excellence with Amaris Consulting as a Pharmaceutical MES Program Leader in Toronto. This role offers a hybrid work mode and requires significant experience in program management.
The MES Program Manager will lead large-scale initiatives in a regulated pharmaceutical environment, leveraging 7-10 years of industry experience. Candidates should excel in managing complex stakeholder relationships, ensuring alignment of project objectives, and overseeing technical execution. A strong foundation in validation practices and regulatory compliance is essential.
Key Responsibilities:
• Lead MES projects through all development phases
• Coordinate across manufacturing, IT, and quality assurance teams
• Manage integrations with systems like PLCs and ERP platforms
• Ensure compliance in Computer System Validation processes
• Track program risks, budget, and resource allocations
Requirements:
• 7-10 years managing MES programs in pharma/biotech
• Proven exper...
The MES Program Manager will lead large-scale initiatives in a regulated pharmaceutical environment, leveraging 7-10 years of industry experience. Candidates should excel in managing complex stakeholder relationships, ensuring alignment of project objectives, and overseeing technical execution. A strong foundation in validation practices and regulatory compliance is essential.
Key Responsibilities:
• Lead MES projects through all development phases
• Coordinate across manufacturing, IT, and quality assurance teams
• Manage integrations with systems like PLCs and ERP platforms
• Ensure compliance in Computer System Validation processes
• Track program risks, budget, and resource allocations
Requirements:
• 7-10 years managing MES programs in pharma/biotech
• Proven exper...
Apply for this Job
Submit your application for the Pharmaceutical MES Program Leader position at AMARIS GROUP SA.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
toronto, Canada
Posted:
June 04, 2026
Deadline:
July 14, 2026